Cargando…
Locally advanced head and neck squamous cell carcinoma treatment efficacy and safety: a systematic review and network meta-analysis
Head and neck squamous cell carcinoma (HNSCC) accounts for approximately 3% of new cancer cases and 3% of all deaths worldwide. Most HNSCC patients are locally advanced (LA) at diagnosis. The combination of radiotherapy (RT), chemotherapy, targeted therapy, and immunotherapy are the primary LA-HNSCC...
Autores principales: | Wang, Huanhuan, Zheng, Zhuangzhuang, Zhang, Yangyu, Bian, Chenbin, Bao, Jindian, Xin, Ying, Jiang, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10546034/ https://www.ncbi.nlm.nih.gov/pubmed/37795033 http://dx.doi.org/10.3389/fphar.2023.1269863 |
Ejemplares similares
-
Copper homeostasis and cuproptosis in tumor pathogenesis and therapeutic strategies
por: Bian, Chenbin, et al.
Publicado: (2023) -
Immunotherapy Advances in Locally Advanced and Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma and Its Relationship With Human Papillomavirus
por: Wang, Huanhuan, et al.
Publicado: (2021) -
Shikimic acid (SA) inhibits neuro-inflammation and exerts neuroprotective effects in an LPS-induced in vitro and in vivo model
por: Bao, Xueying, et al.
Publicado: (2023) -
Functions and mechanisms of lactylation in carcinogenesis and immunosuppression
por: Su, Jing, et al.
Publicado: (2023) -
Efficacy and Safety of Apatinib in Advanced Hepatocellular Carcinoma: A Multicenter Real World Retrospective Study
por: Zheng, Zhuangzhuang, et al.
Publicado: (2022)